Jing Yang, PhD

Clinical Director
Merck & Co., Inc.

Jing Yang, DMD, MS, Sr. Principle Scientist/Clinical Director, Merck & Co.

Poster(s):

• 1509 - Nemtabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Cohort J of the Phase 2 BELLWAVE-003 Study